XML 50 R18.htm IDEA: XBRL DOCUMENT
v3.22.1

Licensing Agreement | 12 Months Ended
--- | ---
Dec. 31, 2021
Licensing Agreement [Abstract] |
Licensing Agreement | 11. Licensing Agreement Cell Line License Agreement with WuXi Biologics (Hong Kong) Limited In October 2019, the Company entered into a cell line license agreement with WuXi Biologics (Hong Kong) Limited (“WuXi Bio”). Under the license agreement, WuXi Bio granted the Company a non-exclusive, worldwide, sublicensable, under certain of WuXi Bio’s intellectual property rights, know-how and biological materials (“WuXi Bio Licensed Technology”), to make, use, sell, offer for sale and import a product developed through the use of the WuXi Bio Licensed Technology (“WuXi Bio Licensed Product”). The WuXi Bio Licensed Technology is currently used to manufacture a component of the Company’s ImmunoTAC platform. The Company has paid an aggregate of $150,000 in license fees that were recorded in research and development expense when incurred. In the event the Company manufactures its commercial supplies of a product produced by the Licensed Cell Line using a manufacturer other than WuXi Bio or its affiliates, the Company will become obligated to pay WuXi Bio aggregate milestone payments, upon achievement of certain sales milestones, of up to $10.8 million. The Company has the right to terminate the license by giving at least six months prior written notice to WuXi Bio and paying all amounts due to them through the termination date. In the event the Company fails to pay all amounts due to WuXi Bio under the license agreement, and fails to pay the amounts within 30 days after receiving written notice of such failure, WuXi Bio may terminate the license with 45 days written notice to the Company. In the event either party commits a material breach under the license and fails to cure the breach within 30 days after receiving written notice from the other party of such breach, either party may terminate the license immediately upon written notice to the other party.

X
- Definition Licensing Agreement. + References No definition available. + Details
Name: | sbtx_LicensingAgreementAbstract
Namespace Prefix: | sbtx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for licensing agreement. + References No definition available. + Details
Name: | sbtx_LicensingAgreementTextBlock
Namespace Prefix: | sbtx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration